Deep search
Rewards
Search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Trending on Bing
Mob ransacks CA mini-mart
Donors demand resignation
Blames 'internet culture'
Cancels tour dates
Body found in sleeping bag
Given ovation in rare visit
Judge declines to dismiss suit
Loses deals following arrest
Actress Belushi-Pisano dies
Lake fire grows: 12K acres
NJ forest fire 65% contained
Criticizes US-China chip war
Speaks at Essence Festival
Judge pauses some deadlines
Frozen garbage on Everest
RU wrestlers reject invitation
Hamas awaits ISR response
'Moana' in the works
Remains found in sleeping bag
Mars mission wraps up
NBA Summer League debut
Pays tribute to Jon Landau
PA Capitol bomb threat
11 killed in Nepal landslides
Israelis push Gaza deal
Beats Artem Harutyunyan
Notches 1,000th career hit
Rookie's historic game
'Cross' sets premiere date
Pink resumes tour
NBA free agency 2024
49 drowned across Russia
Nate Diaz beats Masvidal
Drops 'Not Like Us' video
1st rookie triple-double
Claims racial attack
NY-Boston service resumes
Oscar-winning producer dies
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Alzheimer
FDA approves new early-stage Alzheimer's drug
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
FDA approves a second Alzheimer’s drug that can modestly slow disease
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that's been convincingly shown to slow the memory-destroying condition.
FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
Yahoo Style UK on MSN
1d
'Microdosing' candies linked to illness, death, and a new Alzheimer's drug: A look at health stories you may have missed
Hello, health and wellness readers. My name is Kaitlin, your guide to the latest health news you may have missed. First, ...
1d
on MSN
'It's a sad, sad disease': Local researchers work to bring new Alzheimer's drugs to patients
Doctors at the Roskamp Institute aim to treat around 10,000 patients a year with the new drugs and provide resources to area ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback